Supplements · Metabolic & Cardiometabolic
fatty fish decreases coronary heart disease risk
In plain terms: Does eating oily fish protect your heart?
Part of: • Fatty fish
Most observational studies link eating oily fish to fewer heart-disease deaths. Some recent large studies found no clear benefit, and fish-oil capsule trials have mostly come up empty, so the evidence favours eating fish, not taking supplements.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
Eating oily fish (salmon, mackerel, sardines) is associated with lower coronary heart disease death in most observational meta-analyses — a classic finding. But the picture has become more nuanced: several recent large cohorts found no clear benefit for unprocessed fish, and — importantly — big Cochrane reviews of omega-3 supplement trials show little or no effect on cardiovascular death.
The evidence (16)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Whelton SP, He J, Whelton PK, Muntner P 2004 · Am J Cardiol | meta-analysis | supports | moderate | Meta of observational studies: fish consumption associated with lower fatal and total CHD. |
| Djuricic I, Calder PC 2025 · Current atherosclerosis reports | observational | supports | moderate | Narrative review (2020-2025 evidence) reports updated cohort data and recent meta-analyses consistently link higher dietary intake or circulating levels of EPA/DHA to reduced cardiovascular event risk, though individual RCTs are variable an |
| Oomen CM, Feskens EJ, Räsänen L, Fidanza F, Nissinen AM, Menotti A, Kok FJ, Kromhout D 2000 · Am J Epidemiol | observational | supports | moderate | Seven Countries Study: fish inversely associated with CHD mortality, effect attributed to fatty fish. |
| Steur M, Johnson L, Sharp SJ, Imamura F, Sluijs I, Key TJ, Wood A, Chowdhury R, Guevara M, Jakobsen MU, Johansson I, Koulman A, Overvad K, Sánchez MJ, van der Schouw YT, Trichopoulou A, Weiderpass E, Wennberg M, Zheng JS, Boeing H, Boer JMA, Boutron-Ruault MC, Ericson U, Heath AK, Huybrechts I, Imaz L, Kaaks R, Krogh V, Kühn T, Kyrø C, Masala G, Melander O, Moreno-Iribas C, Panico S, Quirós JR, Rodríguez-Barranco M, Sacerdote C, Santiuste C, Skeie G, Tjønneland A, Tumino R, Verschuren WMM, Zamora-Ros R, Dahm CC, Perez-Cornago A, Schulze MB, Tong TYN, Riboli E, Wareham NJ, Danesh J, Butterworth AS, Forouhi NG 2021 · Eur J Epidemiol | observational | mixed | high | EPIC-CVD case-cohort (9 countries): fish-CHD associations modest and vary by macronutrient substitution. |
| Krittanawong C, Isath A, Hahn J, Wang Z, Narasimhan B, Kaplin SL, Jneid H, Virani SS, Tang WHW 2020 · Adv Nutr | observational | mixed | moderate | SR: fish-CVD event associations inconsistent across studies reviewed. |
| Shao MY, Jiang CQ, Zhang WS, Zhu F, Jin YL, Woo J, Cheng KK, Lam TH, Xu L 2021 · Br J Nutr | observational | tested-null | moderate | Guangzhou Biobank: fish not clearly associated with reduced CVD/IHD/stroke mortality (Chinese cohort). |
| Bellavia A, Larsson SC, Wolk A 2017 · J Intern Med | observational | supports | moderate | Swedish cohort: moderate fish consumption associated with lower all-cause mortality; dose-response present. |
| Torfadottir JE, Ulven SM 2024 · Food Nutr Res | observational | supports | moderate | Nordic scoping review: moderate-certainty evidence fish intake reduces CHD/CVD risk. |
| Abdelhamid AS, Brown TJ, Brainard JS, Biswas P, Thorpe GC, Moore HJ, Deane KH, AlAbdulghafoor FK, Summerbell CD, Worthington HV, Song F, Hooper L 2018 · Cochrane Database Syst Rev | meta-analysis | contradicts | moderate | Cochrane 2018 (pub3; 79 RCTs, 112,059 pts, mostly LCn3 CAPSULES, some enriched foods/dietary advice; no separate fatty-fish estimate). LCn3 vs usual/lower intake: CHD mortality RR 0.93 (0.79-1.09; 21 RCTs, 73,491 pts); CHD events RR 0.93 (0.88-0.97; 28 RCTs, 84,301 pts) not maintained in sensitivity analyses - 'probably makes little or no difference to CHD event risk' (moderate GRADE). Exposure is omega-3 (supplement) not fatty fish; superseded by the 2020 update (fish-abdelhamid-2020) of the same review. |
| Chen X, Chen L, Yang X, Zhang Z 2025 · Frontiers in nutrition | observational | supports | low | GBD 204-country ecological analysis (1990-2021) found seafood omega-3 fatty acid deficiency as a dietary risk factor was a significant contributor to rising ischemic heart disease DALYs and mortality, especially in lower-SDI regions. |
| Jayedi A, Shab-Bidar S, Eimeri S, Djafarian K 2018 · Public Health Nutr | meta-analysis | supports | moderate | Dose-response meta of cohorts: nonlinear inverse fish-all-cause/CVD mortality. |
| Zhong VW, Van Horn L, Greenland P, Carnethon MR, Ning H, Wilkins JT, Lloyd-Jones DM, Allen NB 2020 · JAMA Intern Med | observational | tested-null | high | Pooled US cohorts (JAMA IM): unprocessed fish NOT significantly associated with CVD/all-cause mortality. |
| Giosuè A, Calabrese I, Lupoli R, Riccardi G, Vaccaro O, Vitale M 2022 · Mayo Clin Proc | meta-analysis | supports | moderate | SR+meta: fatty fish (but not lean fish alone) associated with reduced CVD/all-cause mortality. |
| Huang H, Lu X, Van Nguyen S, Chen S, Liu J, Liu Y 2025 · Human genomics | observational | mixed | moderate | UK Biobank cohort (n~large, adjusted HR=0.86, 95%CI 0.81-0.90) found higher circulating omega-3 levels associated with lower acute MI risk, but Mendelian randomization found genetically predicted omega-3 levels associated with INCREASED AMI |
| Abdelhamid AS, Brown TJ, Brainard JS, Biswas P, Thorpe GC, Moore HJ, Deane KH, Summerbell CD, Worthington HV, Song F, Hooper L 2020 · Cochrane Database Syst Rev | meta-analysis | supports | low | Cochrane CD003177 2020 update (pub5; 86 RCTs, 162,796 pts, 12-88 mo; 'Most trials assessed LCn3 supplementation with capsules'; 'There is little evidence of effects of eating fish' - no separate fatty-fish estimate). LCn3 vs usual/lower intake: CHD events RR 0.91 (0.85-0.97; 32 RCTs, 134,116 pts; NNTB 167) and CHD mortality RR 0.90 (0.81-1.00; 24 RCTs, 127,378 pts; NNTB 334), both LOW-certainty; authors: LCn3 'slightly reduces risk of coronary heart disease mortality and events ... (evidence mainly from supplement trials)'. All-cause mortality RR 0.97 (0.93-1.01; 45 RCTs, high-certainty) - little/no effect. Exposure is omega-3 (mostly capsules), not fatty fish; supersedes fish-abdelhamid-2018 (same review). |
| König A, Bouzan C, Cohen JT, Connor WE, Kris-Etherton PM, Gray GM, Lawrence RS, Savitz DA, Teutsch SM 2004 · Circulation | meta-analysis | supports | moderate | Quantitative meta of cohorts: inverse dose-response between fish consumption and CHD mortality. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.